Literature DB >> 22326869

Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells.

Miki Nagai1, Tomomi Furihata, Sayaka Matsumoto, Seiya Ishii, Shinichiro Motohashi, Ichiro Yoshino, Miyuki Ugajin, Atsushi Miyajima, Shogo Matsumoto, Kan Chiba.   

Abstract

Organic anion transporting polypeptide 1B3 (OATP1B3) is a hepatocyte plasma membrane protein that transports various endogenous and xenobiotic compounds. Although it is exclusively expressed in the human liver under normal conditions, OATP1B3 can be also expressed in various human cancer tissues that have been associated with prognosis and clinical outcomes. However, despite the potential significance of the latter finding, no experimental evidence addressing the molecular entity of cancer-associated OATP1B3 has been provided to date. In this paper, we report the identification of a new OATP1B3 mRNA isoform expressed in human colon and lung cancer tissues, which we named cancer-type OATP1B3 (Ct-OATP1B3). Our results also make known a previously unidentified transcription start site and an alternative promoter region, localized at intron 2, from which Ct-OATP1B3 mRNA is generated. Isoform specific mRNA quantification showed that the Ct-OATP1B3 mRNA level was strikingly higher than that of Lt-OATP1B3 mRNA in human cancer tissues. In addition, the results showed that the translation occurred at three out of four open reading frames. To summarize, our results clearly demonstrate that the newly-identified Ct-OATP1B3 (but not Lt-OATP1B3) is the primary mRNA isoform, at least in the human cancerous samples we have examined. In line with the possibility that its translation products play important biological roles in cancer cells, we strongly believe that the existence of Ct-OATP1B3 should be taken into account during future studies of OATP1B3 associated with cancer prognosis and clinical outcomes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326869     DOI: 10.1016/j.bbrc.2012.01.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Epigenetic regulation of organic anion transporting polypeptide 1B3 in cancer cell lines.

Authors:  Satoki Imai; Ryota Kikuchi; Yuri Tsuruya; Sotaro Naoi; Sho Nishida; Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2013-06-28       Impact factor: 4.200

2.  The design and optimization of RNA trans-splicing molecules for skin cancer therapy.

Authors:  Christina Gruber; Ulrich Koller; Eva M Murauer; Stefan Hainzl; Clemens Hüttner; Thomas Kocher; Andrew P South; Helmut Hintner; Johann W Bauer
Journal:  Mol Oncol       Date:  2013-08-19       Impact factor: 6.603

Review 3.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

4.  Different interaction profiles of direct-acting anti-hepatitis C virus agents with human organic anion transporting polypeptides.

Authors:  Tomomi Furihata; Shogo Matsumoto; Zhongguo Fu; Akihito Tsubota; Yuchen Sun; Sayaka Matsumoto; Kaoru Kobayashi; Kan Chiba
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 5.  Alternative Splicing: Expanding Diversity in Major ABC and SLC Drug Transporters.

Authors:  Ji Eun Park; Gongmi Ryoo; Wooin Lee
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

Review 6.  Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy.

Authors:  Nilay Thakkar; A Craig Lockhart; Wooin Lee
Journal:  AAPS J       Date:  2015-03-04       Impact factor: 4.009

7.  Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx.

Authors:  Tristan M Sissung; Ariel M Ley; Jonathan D Strope; Edel M McCrea; Shaunna Beedie; Cody J Peer; Suneet Shukla; Jennifer van Velkinburgh; Kelie Reece; Sarah Troutman; Tessa Campbell; Elena Fernandez; Phoebe Huang; Jordan Smith; Nilay Thakkar; David J Venzon; Stefan Brenner; Wooin Lee; Maria Merino; Ji Luo; Walter Jager; Douglas K Price; Cindy H Chau; William D Figg
Journal:  Mol Cancer Res       Date:  2017-04-07       Impact factor: 5.852

Review 8.  Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology.

Authors:  Rachael R Schulte; Richard H Ho
Journal:  Mol Pharmacol       Date:  2019-02-19       Impact factor: 4.436

Review 9.  The SLCO (former SLC21) superfamily of transporters.

Authors:  Bruno Hagenbuch; Bruno Stieger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

10.  Characterization of Liver- and Cancer-type-Organic Anion Transporting Polypeptide (OATP) 1B3 Messenger RNA Expression in Normal and Cancerous Human Tissues.

Authors:  Khondoker Alam; Taleah Farasyn; Kai Ding; Wei Yue
Journal:  Drug Metab Lett       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.